Amphotericin B liposomal · Medicine question

Is Amphotericin B SUN Pharma liposomal indicated for visceral leishmaniasis in immunocompetent patients?

Name: Is Amphotericin B SUN Pharma liposomal indicated for visceral leishmaniasis in immunocompetent patients?
Published: 2026-11-08T01:28:21.008Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Yes, Amphotericin B SUN Pharma liposomal is indicated for treating visceral leishmaniasis in immunocompetent adults and children aged 1 month to 18 years.

Sources for this answer

Amphotericin B SUN Pharma liposomal 50 mg powder for dispersion for infusionRanbaxy (UK) Limited a Sun Pharmaceutical Company · emc · SmPC §4.1 Therapeutic Indications · Version 1Document updated 27 August 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about Amphotericin B liposomal